FDA Inspection 934385 — bioLytical Laboratories, Inc.

bioLytical Laboratories, Inc. — FEI 3003871407

The FDA completed an inspection of bioLytical Laboratories, Inc. on Jul 9, 2015 in Richmond. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 9, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Richmond (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.